SHINGRIX is a vaccine used in adults 50 years of age and older to protect against shingles (herpes zoster) and post-herpetic neuralgia (long-lasting nerve pain following shingles).
It can also be used in adults 18 years of age and older who are at increased risk of herpes zoster.
The vaccination schedule consists of two doses: an initial dose, followed by a second dose 2 months later. If flexibility in the vaccination schedule is necessary, the second dose can be administered between 2 and 6 months after the first dose. Based on your medical condition, your doctor may also recommend that you receive the second injection 1 month after the first injection.
For further information please consult the Patient information leaflet (PIL).